137 related articles for article (PubMed ID: 19023151)
1. Prognostic significance of plasma osteopontin levels in patients undergoing percutaneous coronary intervention.
Kato R; Momiyama Y; Ohmori R; Tanaka N; Taniguchi H; Arakawa K; Nakamura H; Ohsuzu F
Circ J; 2009 Jan; 73(1):152-7. PubMed ID: 19023151
[TBL] [Abstract][Full Text] [Related]
2. Serum resistin levels and cardiovascular events in patients undergoing percutaneous coronary intervention.
Momiyama Y; Ohmori R; Uto-Kondo H; Tanaka N; Kato R; Taniguchi H; Arakawa K; Nakamura H; Ohsuzu F
J Atheroscler Thromb; 2011; 18(2):108-14. PubMed ID: 21071880
[TBL] [Abstract][Full Text] [Related]
3. Joint effects of N-terminal pro-B-type-natriuretic peptide and C-reactive protein vs angiographic severity in predicting major adverse cardiovascular events and clinical restenosis after coronary angioplasty in patients with stable coronary artery disease.
Dai DF; Hwang JJ; Lin JL; Lin JW; Hsu CN; Lin CM; Chiang FT; Lai LP; Hsu KL; Tseng CD; Tseng YZ
Circ J; 2008 Aug; 72(8):1316-23. PubMed ID: 18654020
[TBL] [Abstract][Full Text] [Related]
4. A novel predictor of restenosis and adverse cardiac events: asymmetric dimethylarginine.
Ari H; Ari S; Erdoğan E; Tiryakioğlu O; Ustündağ Y; Huysal K; Koca V; Bozat T
Heart Vessels; 2010 Jan; 25(1):19-26. PubMed ID: 20091394
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of osteopontin before and 24 h after percutaneous coronary intervention.
Georgiadou P; Iliodromitis EK; Kolokathis F; Mavroidis M; Andreadou I; Demopoulou M; Varounis Ch; Capetanaki Y; Boudoulas H; Kremastinos DT
Expert Opin Ther Targets; 2008 Dec; 12(12):1477-80. PubMed ID: 19007317
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of multiple biomarkers in stable patients undergoing fractional flow reserve-guided coronary angioplasty.
Fracassi F; Niccoli G; Scalone G; Di Gioia G; Conte M; Bartunek J; Sgueglia GA; De Bruyne B; Montone RA; Wijns W; Crea F; Barbato E
J Cardiovasc Med (Hagerstown); 2016 Sep; 17(9):687-93. PubMed ID: 26627500
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein plasma levels but not factor VII activity predict clinical outcome in patients undergoing elective coronary intervention.
Grander W; Dichtl W; Prokop W; Roithinger FX; Moes N; Friedrich G; Weidinger F; Pachinger O
Clin Cardiol; 2004 Apr; 27(4):211-6. PubMed ID: 15119695
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin plasma levels and accelerated atherosclerosis in patients with CAD undergoing PCI: a prospective clinical study.
Mazzone A; Parri MS; Giannessi D; Ravani M; Vaghetti M; Altieri P; Casalino L; Maltinti M; Balbi M; Barsotti A; Berti S
Coron Artery Dis; 2011 May; 22(3):179-87. PubMed ID: 21407077
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic value of plasma brain natriuretic peptide and C-reactive protein in patients with acute coronary syndromes underwent percutaneous coronary intervention].
He B; Ding S; Pu J; Liu JP; Song W; Du YP; Shen JY; Jin SX; Sun Y; Shen L
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):349-52. PubMed ID: 16776932
[TBL] [Abstract][Full Text] [Related]
10. Preprocedural C-reactive protein is not associated with angiographic restenosis or target lesion revascularization after coronary artery stent placement.
Rittersma SZ; de Winter RJ; Koch KT; Schotborgh CE; Bax M; Heyde GS; van Straalen JP; Mulder KJ; Tijssen JG; Sanders GT; Piek JJ
Clin Chem; 2004 Sep; 50(9):1589-96. PubMed ID: 15205368
[TBL] [Abstract][Full Text] [Related]
11. Combined periprocedural evaluation of CRP and TNF-alpha enhances the prediction of clinical restenosis and major adverse cardiac events in patients undergoing percutaneous coronary interventions.
Kubica J; Kozinski M; Krzewina-Kowalska A; Zbikowska-Gotz M; Dymek G; Sukiennik A; Piasecki R; Bogdan M; Grzesk G; Chojnicki M; Dziedziczko A; Sypniewska G
Int J Mol Med; 2005 Jul; 16(1):173-80. PubMed ID: 15942695
[TBL] [Abstract][Full Text] [Related]
12. An elevated value of C-reactive protein is the only predictive factor of restenosis after percutaneous coronary intervention.
Jeong WK; Jeong MH; Kim KH; Lee SR; Park OY; Yum JH; Kim JH; Kim W; Rhew JY; Ahn YK; Cho JG; Ahn BH; Suh SP; Park JC; Kim SH; Kang JC
Korean J Intern Med; 2003 Sep; 18(3):154-60. PubMed ID: 14619384
[TBL] [Abstract][Full Text] [Related]
13. Prognostic values of C-reactive protein levels on clinical outcome after implantation of sirolimus-eluting stents in patients on hemodialysis.
Ishii H; Toriyama T; Aoyama T; Takahashi H; Amano T; Hayashi M; Tanaka M; Kawamura Y; Yasuda Y; Yuzawa Y; Maruyama S; Matsuo S; Matsubara T; Murohara T
Circ Cardiovasc Interv; 2009 Dec; 2(6):513-8. PubMed ID: 20031768
[TBL] [Abstract][Full Text] [Related]
14. High osteopontin levels predict long-term outcome after STEMI and primary percutaneous coronary intervention.
Bjerre M; Pedersen SH; Møgelvang R; Lindberg S; Jensen JS; Galatius S; Flyvbjerg A
Eur J Prev Cardiol; 2013 Dec; 20(6):922-9. PubMed ID: 23613225
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein(a), interleukin-10, C-reactive protein, and 8-year outcome after percutaneous coronary intervention.
Kardys I; Oemrawsingh RM; Kay IP; Jones GT; McCormick SP; Daemen J; Van Geuns RJ; Boersma E; Van Domburg RT; Serruys PW
Clin Cardiol; 2012 Aug; 35(8):482-9. PubMed ID: 22488248
[TBL] [Abstract][Full Text] [Related]
16. Association between plasma pregnancy-associated plasma protein a and restenosis after percutaneous coronary angioplasty.
Li XP; Zhou SH; Tang JJ; Liu QM; Fang ZF; Hu XQ; Zhou T; Sheng XQ; Zhao SP
Circ J; 2008 May; 72(5):729-33. PubMed ID: 18441451
[TBL] [Abstract][Full Text] [Related]
17. Plasma osteopontin concentration is elevated in patients with coronary bare metal stent restenosis.
Yilmaz KC; Bal UA; Karacaglar E; Okyay K; Aydinalp A; Yildirir A; Muderrisoglu H
Acta Cardiol; 2018 Feb; 73(1):69-74. PubMed ID: 28841817
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events and restenosis in patients undergoing coronary stent implantation: a prospective study.
Akcakoyun M; Kargin R; Tanalp AC; Pala S; Ozveren O; Akcay M; Barutcu I; Kirma C
Coron Artery Dis; 2008 Aug; 19(5):337-43. PubMed ID: 18607171
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of preprocedural C reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantation.
Park DW; Lee CW; Yun SC; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Heart; 2007 Sep; 93(9):1087-92. PubMed ID: 17309906
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin as a novel prognostic marker in stable ischaemic heart disease: a 3-year follow-up study.
Georgiadou P; Iliodromitis EK; Kolokathis F; Varounis C; Gizas V; Mavroidis M; Capetanaki Y; Boudoulas H; Kremastinos DT
Eur J Clin Invest; 2010 Apr; 40(4):288-93. PubMed ID: 20192976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
